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Electrophysiological technique was performed to detect the effect of anti-P2X7R antibody on CSD.  
Real time PCR was then performed to analyze the gene level of IL-1β and TNF-α post CSD with or without antibody treatment 
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•  The purinergic P2X7 receptors, are ionotropic membrane channels, which can be activated by extracellular ATP. 
•  ATP is known to be involved cortical spreading depression (CSD), a substrate of migraine [1, 2] . 
•  P2X7R activation promotes IL-1β[3] and TNF-α[4] release and CSD triggers these neuroinflammatory factors 
release[5] . 
•  Inhibition of the P2X7-Panx1 complex suppresses spreading depolarization in rats and the induction of IL-1β post 
CSD [6]  
•  Whether the anti-P2X7R antibody could suppress CSD and the subsequent induction of neuroinflammatory factors is 
unknown. 
•  To examine the effects of anti-P2X7R antibody on cortex susceptibility to CSD. 
•  To address whether P2X7R contributes to the induction of IL-1β and TNF-α induced by CSD
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Figure 1. Schematic representation of surgical coordinates on parietal bone 
of isoflurane anaesthetic rats. 
Figure 2. Representative trace in DC potential of CSD wave. 
Latency: the time required to elicit the 1st CSD wave from the 
start of high K+ application. 
Figure 3. Timeline of the in vivo experiment with sequence of 
pharmacological and electrophysiological performance 
followed by tissue dissection for the subsequent molecular 
analysis. 
•  Blockade of  P2X7R by antibody reduced cortex susceptibility to CSD and rapidly reduced CSD induced gene 
expression of TNF-α in rats, indicating P2X7R as a potential target for migraine prophylaxis and treatment. 
•  The anti-P2X7R antibody did not reduce the induction of gene expression of IL-1β immediately after CSD. This may be 
due to: 1) the time points, as a significant down-regulation of IL-1β mRNA level was reported by inhibition of the 
P2X7/PANX1 pore complex 4 hours post CSD[6]. 2) suppression of spreading depolarization-induced IL-1β mRNA 
upregualtion was due to inhibition of the P2X7/PANX1 pore complex, not the P2X7R cation channel [6]. 
1. Anti-P2X7R antibody suppressed CSD in rats
Figure 5. gene expression of TNF-α and IL-1β, (n=5 in glycerol sham group and n=8 in 
another two group). *p < 0.05, **p < 0.01, ****p<0.0001. Two-tailed unpaired t-test. 
Figure 4. The anti-P2X7R antibody reduced cortex susceptibility to CSD in rats. (n=8 in 
each group) *p < 0.05, **p < 0.01. Two-tailed, unpaired t-test. 
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2. Anti-P2X7R antibody reduced the induction of  
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